3652 results for «384»
3652 results
Innovations in managing calcified lesions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover advanced strategies for dealing with challenging calcified lesions in this session: learn how to tackle complex situations, including diffuse and heavily calcified lesions, and discover innovative techniques for addressing angulated calcified lesions in the left anterior descending artery and other vessels.
Uncommon complications in NSTEMI
22 Sep 2023 – From AICT-AsiaPCR 2023
Discoversome unforeseen challenges in NSTEMI cases in this session, ranging from managing coronary air embolisms and distinguishing between inflammation and infarction to dealing with coronary aneurysms at the left main coronary artery bifurcation and addressing type 5 coronary perforation.
Advanced techniques for managing calcified lesions
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover advanced strategies for tackling complex calcified lesions in this session: from innovative approaches like the 'Orbital-shock' technique to managing calcified lesions in patients with previous CABG and in-stent restenosis, and exploring calcium modification strategies tailored to specific cases, these presentations offer valuable insights into simplifying...
Complex CTO challenges
22 Sep 2023 – From AICT-AsiaPCR 2023
Gain valuable insights into overcoming CTO challenges in this session: learn how IVUS can come to the rescue in cases of main branch cut-off, discover successful recanalization techniques for right coronary artery CTOs using very long epicardial channels and explore the best approaches for managing complex...
Learning - Cardiogenic shock
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore the complexities of cardiogenic shock management in this session: understand its pathophysiology, learn about the role of mechanical support (IABP, Impella, ECMO) in addition to pharmacological treatment, gather tips and tricks from expert speakers and gain insights into real-world cases.
Other valvular interventions
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore innovative approaches to various valvular interventions in this session: from managing post-mitral valve replacement complications and performing balloon mitral valvotomy in patients with restenosis after mitral valve interventions to tackling calcified mitral valves and addressing unique cases like LBB pacing in isolated ccTGA with complete...
How to manage complications in CTO PCI
22 Sep 2023 – From AICT-AsiaPCR 2023
Explore complex CTO PCI scenarios and gain insights into complications and their solutions in this session. Topics include CTO vessel rupture after a covered stent bailout, epicardial channel perforation management, dissection from collateral tip injection, and more!
Spontaneous coronary artery disease, INOCA, MINOCA in women
21 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session to better understand the causes of myocardial infarction without obstructive disease (MINOCA), to revisit ischemia with no obstructive coronary atherosclerosis (INOCA), and to broaden your understanding of spontaneous coronary artery dissection (SCAD) beyond its association with pregnancy.
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial
03 Sep 2025
Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
From PROTECT-AF to CHAMPION-AF: Where do we stand today?
01 Jul 2026
In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.
Author
